But with plans to ease cost concerns. The first gene therapy in the U.S., approved last month to treat a rare, inherited form of blindness, now has a price tag: $850,000

Quick Read

In type 1 diabetes, the body engages in warfare with itself, the immune system mistakenly treating the insulin-producing cells of the pancreas as a harmful invader, destroying the cells along with the body’s ability to regulate sugar. Typically diagnosed in youth, it has no cure, and patients face a lifetime of insulin injections and complications

Quick Read

BioViva and its controversial CEO Liz Parrish want to bring experimental gene therapies to patients prior to approval by regulators in a quest to cure aging

Quick Read

When the government says a new drug is approved for sale, the first thing many companies do is announce what it will cost. Not Spark Therapeutics, though

Quick Read

Doctors took his stem cells, corrected a faulty mutation within them, and used them to replace 80 percent of his skin

Quick Read

Who will pay for it? And how?

Quick Read

A one-time gene therapy that costs half a million dollars sounds crazy until you add up what it costs to treat some diseases over a lifetime

Quick Read

The first gene therapy treatment in the United States was approved recently by the Food and Drug Administration, heralding a new era in medicine that is coming faster than most realize — and that perhaps few can afford

Quick Read